NMTC NeuroOne Medical Technologies Corp

$NMTC Our Evo electrodes and OneRF brain ablation system will be showcased alongside Zimmer Biomet and Monteris technologies at the 2026 CNS Annual Meeting, October 31–November 4 in Washington, D.C., at Booth #649. Commercialized through our distribution partnership with Zimmer Biomet, these technologies support electrical recording and targeted radiofrequency ablation. OneRF enables diagnostic recording and ablation using the same sEEG electrode, connecting information gathering with treatment. Together with ROSA Brain’s robotic planning and guidance and NeuroBlate’s laser ablation, our products contribute to a portfolio spanning navigation, localization and ablation. CNS provides an opportunity for neurosurgeons to explore these complementary capabilities and see the practical role of NeuroOne’s technology within the broader workflow.

$NMTC Today, we published preliminary product revenue results for fiscal Q4 and full-year 2026, reflecting continued commercial growth and a strong finish to the fiscal year. Q4 product revenue is expected to reach approximately $3.8 million, up 38.4% year over year. Full-year product revenue is expected to reach approximately $10.5 million, representing 15.6% growth and landing at the top of our previously announced guidance range of $9.2 million to $10.5 million. Reaching the upper end of that range marks an important execution milestone as we continue working to expand the commercial reach of our neurotechnology portfolio. The fourth-quarter performance also provides a stronger revenue foundation as we begin fiscal 2027. Figures are preliminary and unaudited, and remain subject to year-end accounting and audit procedures. Complete financial results are expected in December 2026.

$NMTC We enter fiscal 2027 with $5.4 million in open purchase orders as of September 30, following a $4.5 million purchase order secured in September—the largest in NeuroOne’s history. Approximately $1 million of the record order shipped in September. Remaining shipments are expected to begin in fiscal Q1 and continue into Q2 2027, subject to manufacturing and delivery schedules. This order provides greater visibility into anticipated product shipments and future revenue opportunities. Across fiscal 2026, product orders increased 24.2% compared with the previous year, adding to the commercial foundation supporting our next phase of execution. Alongside fulfilling these orders, our growth priorities include commercialization of the trigeminal neuralgia system, international market expansion and advancement of our drug delivery platform. These priorities connect our existing commercial business with opportunities to expand the reach and applications of NeuroOne’s technology.

$NMTC i can not even imagine watching my 10 yr old child have 50 seizures in 3 days.... our tech needs to reach more people soon.

$NMTC So, the algos decided to not take this into non compliance. How magnanimous of them. Get it cheap, but don't massacre them because they actually have a good device.

$NMTC delivers preliminary Q4 product revenue up 38.4% and announces a record $4.5 million purchase order.

$NMTC NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

$NMTC can’t hold gains. Company reaching with another average pr trying to prop up before announced dilution. Market is pricing this for at least 50% dilution with their ATM program. Hope it recovers to post split prices but seems very far away with today’s action. Would take a 400% move to get back to where it was 🙄

$NMTC $9.4m valuation! Nice job team. Crushing it. Must be pricing for massive dilution to keep ceos salary alive. Always thought this micro operated differently by not carrying debt and not a crazy cash burn rate. What a mistake that thought was. Just announce dilution already so investors can determine where the value should be.

$NMTC Buying more of this stock every day. While everyone cries about low prices, their muppet mouths will be shut when it rips.

$NMTC Under $10M market cap hahaha. What a dumpster fire. Not a word from them other than spam Stocktwits posts that provide nothing.

This scammer trying to manipulate $NMTC cries about people blocking him, then blocks me. Absolute wanker chump. Hence why he lives with his mother trading her money. Pathetic!

$NMTC 1 to 6 reverse stock split last April. How did that work out for $1 stock price compliance?